About this trial
There is a knowledge gap about the influence of the menstrual cycle on bladder function in women with spinal cord injury. So far, studies regarding urinary incontinence have primarily focused on women after menopause. It has become clear that a lack of the sex hormone estrogen, which occurs after menopause, can lead to urinary incontinence. During the course of the menstrual cycle, women also experience fluctuations in their sex hormones, particularly estrogen. The estrogen level is highest before ovulation and decreases afterwards. The investigators aim to explore whether this drop in hormone levels could lead to more frequent urinary incontinence during this phase. In order to offer the patients optimal treatment for urinary incontinence, it is important to understand the potential causes behind it. Participants will document their menstrual cycles and episodes of urinary incontinences over three menstrual cycles using a diary, and urine tests. This research project is a pilot study and is being conducted by Swiss Paraplegic Research at the Swiss Paraplegic Centre. The investigators are recruiting 12 participants who experience incontinence at least once a month and 12 participants who experience incontinence less frequently or not at all.
Eligibility criteria
Qualifiers
women
age ≥ 18 years
chronic neurogenic bladder dysfunction due to acquired spinal cord injury
regular menstrual cycle (26-30 days/cycle)
Disqualifiers
Detrusor overactivity in storage phase above 15cmH20
Oligomenorrhea or amenorrhea (infrequent or absent menstrual periods)
Hormonal intake/contraception
Intake of androgens
Trial design
Treatments tested in this trial
- Not listed